BioSpace News Archive

Business

IMV Inc. Announces Fourth Quarter and Full Year 2021 Financial and Operational Results

IMV Inc. today announced its financial and operational results, and provided an update for the fourth quarter and year ended December 31, 2021.

March 17, 2022
·
14 min read
FDA

U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for EGFR Therapeutics Targeting Exon 19 Deletions or Exon 21 Substitutions in Non-Small Cell Lung Cancer

Foundation Medicine, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic to identify patients with non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) EGFR exon 19 deletions or exon 21 (L858R) alterations and are appropriate for treatment with EGFR Tyrosine Kinase Inhibitors (TKI) approved by FDA for this indication.

March 17, 2022
·
4 min read
Business

AVROBIO Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update

AVROBIO, Inc. today reported financial results for the fourth quarter and year ended Dec. 31, 2021, and provided a business update.

March 17, 2022
·
12 min read
Business

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Outlook

Apyx Medical Corporation today reported financial results for its fourth quarter and full year ended December 31, 2021, and introduced financial expectations for the full year ending December 31, 2022.

March 17, 2022
·
18 min read
Biotech Bay

Renown French Oncology Research Group Selects ZAP Surgical as Preferred Radiosurgery Brain Tumor Treatment Technology

ZAP Surgical Systems, Inc. today announced that Unicancer , a leading academic promoter of oncology clinical trials and medical equipment purchasing health cooperation group for 19 French comprehensive cancer centers, has selected the ZAP-X ® Gyroscopic Radiosurgery ® platform for cranial stereotactic radiosurgery.

March 17, 2022
·
4 min read
Business

NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Validation

NexImmune, Inc. and Zephyr AI announced a strategic partnership focusing on the discovery and validation of novel targets for new T-cell-mediated therapies in oncology.

March 17, 2022
·
6 min read
Business

Bruce Cozadd joins ACELYRIN, INC. Board of Directors

ACELYRIN, INC. today announced the appointment of Bruce C. Cozadd, co-founder and CEO of Jazz Pharmaceuticals, to its board of directors.

March 17, 2022
·
2 min read
Business

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries

Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries.

March 17, 2022
·
7 min read
Bio NC

Drug Acceleration Experts Launch New Biotech Startup With Eye on Cancer Treatments, Global Partnerships for Patients

The team of entrepreneur physician-scientists who first developed the novel therapeutic RABI-767 for the treatment of severe acute pancreatitis have launched a new biotech startup to accelerate the development of novel therapeutics for major unmet needs and difficult-to-treat diseases.

March 17, 2022
·
4 min read
Pharm Country

Manhattan Scientifics Announces Early Results from Cancer Company

Manhattan Scientifics Inc. ( OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study.

March 17, 2022
·
1 min read